Cover Page - shares	6 Months Ended
Cover Page - shares	Dec. 31, 2020	Jan. 21, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2020
Document Transition Report	false
Entity File Number	1-07151
Entity Registrant Name	THE CLOROX COMPANY
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	31-0595760
Entity Address, Address Line One	1221 Broadway
Entity Address, City or Town	Oakland
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94612-1888
City Area Code	510
Local Phone Number	271-7000
Title of 12(b) Security	Common Stock - $1.00 par value
Trading Symbol	CLX
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		125,791,273
Entity Central Index Key	0000021076
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Net sales	$ 1,842	$ 1,449	$ 3,758	$ 2,955
Cost of products sold	1,005	810	2,001	1,653
Gross profit	837	639	1,757	1,302
Selling and administrative expenses	269	210	507	421
Advertising costs	187	140	366	277
Research and development costs	40	34	72	64
Interest expense	24	25	49	50
Other (income) expense, net	(15)	(5)	(95)	(3)
Earnings before income taxes	332	235	858	493
Income taxes	71	50	180	105
Net earnings	261	185	678	388
Less: Net earnings attributable to noncontrolling interests	2	0	4	0
Net earnings attributable to Clorox	$ 259	$ 185	$ 674	$ 388
Net earnings per share attributable to Clorox
Basic net earnings per share (in dollars per share)	$ 2.06	$ 1.48	$ 5.34	$ 3.09
Diluted net earnings per share (in dollars per share)	$ 2.03	$ 1.46	$ 5.25	$ 3.05
Weighted average shares outstanding (in thousands)
Basic (in shares)	126,216	125,440	126,281	125,632
Diluted (in shares)	128,135	126,879	128,457	127,198
Comprehensive income	$ 309	$ 199	$ 743	$ 389
Less: Total comprehensive income attributable to noncontrolling interests	2	0	4	0
Total comprehensive income attributable to Clorox	$ 307	$ 199	$ 739	$ 389

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Dec. 31, 2020	Jun. 30, 2020
Current assets
Cash and cash equivalents	$ 732	$ 871
Receivables, net	616	648
Inventories, net	609	454
Prepaid expenses and other current assets	146	47
Total current assets	2,103	2,020
Property, plant and equipment, net of accumulated depreciation and amortization of $2,319 and $2,224, respectively	1,221	1,103
Operating lease right-of-use assets	322	291
Goodwill	1,803	1,577
Trademarks, net	788	785
Other intangible assets, net	261	109
Other assets	357	328
Total assets	6,855	6,213
Current liabilities
Current maturities of long-term debt	300	0
Current operating lease liabilities	61	64
Accounts payable and accrued liabilities	1,377	1,329
Income taxes payable	0	25
Total current liabilities	1,738	1,418
Long-term debt	2,483	2,780
Long-term operating lease liabilities	313	278
Other liabilities	813	767
Deferred income taxes	128	62
Total liabilities	5,475	5,305
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 and 158,741,461 shares issued as of December 31, 2020 and June 30, 2020, respectively; and 125,724,327 and 126,198,606 shares outstanding as of December 31, 2020 and June 30, 2020, respectively	131	159
Additional paid-in capital	1,176	1,137
Retained earnings	1,302	3,567
Treasury shares, at cost: 5,017,134 and 32,542,855 shares as of December 31, 2020 and June 30, 2020, respectively	(850)	(3,315)
Accumulated other comprehensive net (loss) income	(575)	(640)
Total Clorox stockholders’ equity	1,184	908
Noncontrolling interests	196	0
Total stockholders’ equity	1,380	908
Total liabilities and stockholders’ equity	$ 6,855	$ 6,213
Common stock, shares issued (in shares)	130,741,461	158,741,461

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2020	Jun. 30, 2020
Statement of Financial Position [Abstract]
Property, plant and equipment, accumulated depreciation and amortization	$ 2,319	$ 2,224
Preferred stock, par value (in dollars per share)	$ 1.00	$ 1.00
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 1.00	$ 1.00
Common stock, shares authorized (in shares)	750,000,000	750,000,000
Common stock, shares issued (in shares)	130,741,461	158,741,461
Common stock, shares outstanding (in shares)	125,724,327	126,198,606
Treasury stock, shares (in shares)	5,017,134	32,542,855

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating activities:
Net earnings	$ 678	$ 388
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	104	88
Stock-based compensation	35	19
Deferred income taxes	41	12
Other	(65)	21
Changes in:
Receivables, net	72	86
Inventories, net	(140)	(3)
Prepaid expenses and other current assets	(17)	(9)
Accounts payable and accrued liabilities	23	(80)
Operating lease right-of-use assets and liabilities, net	0	7
Income taxes payable / prepaid	(102)	(31)
Net cash provided by operations	629	498
Investing activities:
Capital expenditures	(151)	(111)
Businesses acquired, net of cash acquired	(85)	0
Other	(22)	13
Net cash used for investing activities	(258)	(98)
Financing activities:
Notes and loans payable, net	0	106
Treasury stock purchased	(300)	(195)
Cash dividends paid to Clorox stockholders	(280)	(266)
Cash dividends paid to noncontrolling interests	(18)	0
Issuance of common stock for employee stock plans and other	74	17
Net cash used for financing activities	(524)	(338)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	11	(1)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(142)	61
Cash, cash equivalents, and restricted cash:
Beginning of period	879	113
End of period	$ 737	$ 174

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited interim condensed consolidated financial statements for the three and six months ended December 31, 2020 and 2019, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June 30, 2020, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies. Recently Issued Accounting Standards Recently Issued Accounting Standards Not Yet Adopted In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2019-12, “Income Taxes (ASC 740): Simplifying the Accounting for Income Taxes,” which improves consistency in the application of accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and by clarifying and amending existing guidance. The standard will be effective for the Company beginning in the first quarter of fiscal year 2022, with early adoption permitted. The amendments that are related to changes in ownership of foreign equity method investments or foreign subsidiaries are to be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments that are related to franchise taxes that are partially based on income are to be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU are to be applied on a prospective basis. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements. Recently Adopted Accounting Standards In January 2017, the FASB issued ASU No. 2017-04, “Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. The Company adopted this guidance as of July 1, 2020 on a prospective basis, and the adoption did not have a material impact on the Company’s consolidated financial statements, as the Company had no goodwill impairments to date during fiscal year 2021. The future impact of this new standard will depend on the specific facts and circumstances of future impairments that may occur, if any.

BUSINESS ACQUIRED

6 Months Ended

Dec. 31, 2020

Business Combinations [Abstract]

BUSINESS ACQUIRED

Saudi Joint Venture Acquisition

On July 9, 2020, the Company increased its investment in each of the two entities comprising its joint venture in the Kingdom of Saudi Arabia (Saudi joint venture). The joint venture offers customers in the Gulf region a range of cleaning and disinfecting products. The Company had previously accounted for its 30 percent investment of $27 as of June 30, 2020, under the equity method of accounting. Subsequent to the closing of this transaction, the Company’s total ownership interest in each of the entities increased to 51 percent. The Company has consolidated this joint venture into the Company’s consolidated financial statements from the date of acquisition and reflects operations within the International reportable segment. The equity and income attributable to the other joint venture owners is recorded and presented as noncontrolling interests.

The total purchase consideration of $111 consisted of $100 cash paid, which was sourced from operations, and $11 from the net effective settlement of preexisting arrangements between the Company and the joint venture. The assets and liabilities of the joint venture were recorded at their respective estimated fair value as of the acquisition date using generally accepted accounting principles for business combinations. The excess of the purchase price over the fair value of the net identifiable assets acquired has been allocated to goodwill in the International reportable segment in the amount of $208. The goodwill is primarily attributable to the synergies expected to arise after the acquisition and reflects the value of further growth anticipated in the Gulf region. None of the goodwill is deductible for tax purposes.

As a result of this transaction, the carrying value of the Company’s previously held equity investment was remeasured to fair value, and resulted in an $85 non-recurring, non-cash gain recorded in Other (income) expense, net in the condensed consolidated statement of earnings and adjusted in Other operating activities in the condensed consolidated statement of cash flows for the first quarter of fiscal year 2021. The fair values of the noncontrolling interests and previously held equity interest were determined using a discounted cash flow (DCF) method under the income approach. Under this approach, the Company estimates future cash flows and discounts these cash flows at a rate of return that reflects the entities’ relative risk.

The purchase price allocation was finalized during the second quarter of fiscal year 2021. The following table summarizes the final purchase price allocation for the fair value of the joint venture’s assets acquired and liabilities assumed and the related deferred income taxes as of the acquisition date. The fair value of the assets acquired and liabilities assumed reflects the final insignificant measurement period adjustments related to goodwill, deferred income taxes and income taxes payable. The definite-lived intangibles acquired primarily represent the Company reacquiring previously licensed trademarks and customer relationships. The weighted-average estimated useful life of intangible assets subject to amortization is 9 years.


	Joint Venture
Goodwill	$	208
Reacquired rights (included in Other intangible assets, net)	138
Property, plant and equipment	46
Customer relationships (included in Other intangible assets, net)	10
Working capital, net (includes cash acquired of $26)	34
Noncurrent liabilities, net	(5)
Deferred income taxes	(19)
Total fair value of net assets	412
Less: Fair value of noncontrolling interests	(198)
Less: Fair value of previously held equity interest	(103)
Total purchase consideration	$	111

Included in the Company’s results for the three and six months ended December 31, 2020 was $23 and $46, respectively, of net sales from the joint venture. Pro forma results reflecting this transaction were not presented because it is not significant to the Company’s consolidated financial results.

INVENTORIES, NET

6 Months Ended

Dec. 31, 2020

Inventory Disclosure [Abstract]

INVENTORIES, NET

Inventories, net, consisted of the following as of:


	12/31/2020		6/30/2020
Finished goods	$	453	$	340
Raw materials and packaging	178		140
Work in process	10		7
LIFO allowances	(32)		(33)
Total	$	609	$	454

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS

6 Months Ended

Dec. 31, 2020

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS

Financial Risk Management and Derivative Instruments

The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.

Commodity Price Risk Management

The Company may use commodity exchange traded futures and over-the-counter swap contracts, which are generally no longer than 2 years, to fix the price of a portion of its forecasted raw material requirements. Commodity purchase contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.

As of December 31, 2020, the notional amount of commodity derivatives was $21, of which $11 related to soybean oil futures used for the Food products business and $10 related to jet fuel swaps used for the Grilling business. As of June 30, 2020, the notional amount of commodity derivatives was $27, of which $14 related to soybean oil futures and $13 related to jet fuel swaps.

Foreign Currency Risk Management

The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company’s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have durations of no longer than 2 years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.

The notional amounts of outstanding foreign currency forward contracts used by the Company’s subsidiaries to hedge forecasted purchases of inventory were $57 and $70, respectively, as of December 31, 2020 and June 30, 2020.

Interest Rate Risk Management

The Company may enter into over-the-counter interest rate forward or swap contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt or to manage the Company’s level of fixed and floating rate debt. These interest rate forward or swap contracts historically have had durations of less than 3 years. The interest rate contracts are measured at fair value using information quoted by U.S. government bond and interest rate derivative dealers.

The notional amounts of outstanding interest rate contracts used by the Company were $300 and $225, respectively, as of December 31, 2020 and June 30, 2020. These contracts represent forward starting interest rate swap contracts with a maturity date of September 2022 to manage the exposure to interest rate volatility associated with future interest payments on a forecasted debt issuance.

Commodity, Foreign Exchange and Interest Rate Derivatives

The Company designates its commodity forward and futures contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate forward contracts for forecasted interest payments as cash flow hedges.

The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:


	Gains (losses) recognized in Other comprehensive (loss) income
	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Commodity purchase derivative contracts	$	6	$	3	$	7	$	3
Foreign exchange derivative contracts	(2)		(1)		(3)		—
Interest rate derivative contracts	7		—		10		—
Total	$	11	$	2	$	14	$	3


	Location of Gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings	Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings
		Three Months Ended				Six Months Ended
		12/31/2020		12/31/2019		12/31/2020		12/31/2019
Commodity purchase derivative contracts	Cost of products sold	$	(1)	$	(1)	$	(2)	$	(1)
Foreign exchange derivative contracts	Cost of products sold	—		—		—		—
Interest rate derivative contracts	Interest expense	(1)		(1)		(3)		(3)
Total		$	(2)	$	(2)	$	(5)	$	(4)

The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of December 31, 2020, that is expected to be reclassified into Net earnings within the next twelve months is $(6).

Counterparty Risk Management and Derivative Contract Requirements

The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions held as of December 31, 2020 and June 30, 2020, $2 and $3, respectively, contained such terms. As of December 31, 2020 and June 30, 2020, neither the Company nor any counterparty was required to post any collateral, as no counterparty liability position limits were exceeded.

Certain terms of the agreements governing the Company’s over-the-counter derivative instruments require the credit ratings, as assigned by Standard & Poor’s and Moody’s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company’s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both December 31, 2020 and June 30, 2020, the Company and each of its counterparties had been assigned investment grade ratings by both Standard & Poor’s and Moody’s.

Certain of the Company’s exchange-traded futures contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company’s broker for trades conducted on that exchange. As of December 31, 2020 and June 30, 2020, the Company maintained cash margin balances related to exchange-traded futures contracts of $3 and $2, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.

Trust Assets

The Company has held interests in mutual funds and cash equivalents as part of the trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company’s current and former employees, may select among certain mutual funds in which to invest their compensation deferrals in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and, therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.

Fair Value Measurements

Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.

As of December 31, 2020 and June 30, 2020, the Company’s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company’s nonqualified deferred compensation plans, which were classified as Level 1.

All of the Company’s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company’s derivative instruments:


			12/31/2020				6/30/2020
	Balance Sheet Classification	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Commodity purchase futures contracts	Other current assets	1	$	2	$	2	$	—	$	—
Commodity purchase swaps contracts	Other current assets	2	1		1		—		—
Commodity purchase swaps contracts	Other assets	2	1		1		—		—
Interest rate forward contracts	Other assets	2	11		11		1		1
			$	15	$	15	$	1	$	1
Liabilities
Commodity purchase futures contracts	Accounts payable and accrued liabilities	1	$	—	$	—	$	1	$	1
Commodity purchase swaps contracts	Accounts payable and accrued liabilities	2	1		1		3		3
Foreign exchange forward contract	Accounts payable and accrued liabilities	2	3		3		1		1
			$	4	$	4	$	5	$	5

The following table provides information about the balance sheet classification and the fair values of the Company’s other assets and liabilities for which disclosure of fair value is required:


			12/31/2020				6/30/2020
	Balance Sheet Classification	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Investments, including money market funds	Cash and cash equivalents (a)	1	$	306	$	306	$	584	$	584
Time deposits	Cash and cash equivalents (a)	2	285		285		165		165


Trust assets for nonqualified deferred compensation plans	Other assets	1	128		128		100		100
			$	719	$	719	$	849	$	849
Liabilities


Current maturities of long-term debt and Long-term debt	Current maturities of long- term debt and Long-term debt (b)	2	2,783		3,050		2,780		3,051
			$	2,783	$	3,050	$	2,780	$	3,051

____________________

(a)Cash and cash equivalents are composed of time deposits and other interest bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.

(b)Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.

INCOME TAXES	6 Months Ended
INCOME TAXES	Dec. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXESIn determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings was 21.2% and 20.9% for the three and six months ended December 31, 2020, respectively, and 21.0% and 21.3% for the three and six months ended December 31, 2019, respectively. In comparison to the prior six month period, the decrease in the effective tax rate was primarily due to higher excess tax benefits and the non-taxability of a portion of the remeasurement gain recognized on the Company’s previously held investment in the Saudi joint venture, partially offset by a reduced benefit from releases of uncertain tax positions.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

NET EARNINGS PER SHARE (EPS)

6 Months Ended

Dec. 31, 2020

Earnings Per Share [Abstract]

NET EARNINGS PER SHARE (EPS)

The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:


	Three Months Ended		Six Months Ended
	12/31/2020	12/31/2019	12/31/2020	12/31/2019
Basic	126,216	125,440	126,281	125,632
Dilutive effect of stock options and other	1,919	1,439	2,176	1,566
Diluted	128,135	126,879	128,457	127,198

Antidilutive stock options and other	437	1,792	437	1,035

Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Clorox.

COMPREHENSIVE INCOME

6 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

COMPREHENSIVE INCOME

The following table provides a summary of Comprehensive income for the periods indicated:


	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Net earnings	$	261	$	185	$	678	$	388
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments	37		9		47		(7)
Net unrealized gains (losses) on derivatives	10		4		15		6
Pension and postretirement benefit adjustments	1		1		3		2
Total other comprehensive (loss) income, net of tax	48		14		65		1
Comprehensive income	309		199		743		389
Less: Total comprehensive income attributable to noncontrolling interests	2		—		4		—
Total comprehensive income attributable to Clorox	$	307	$	199	$	739	$	389

STOCKHOLDERS' EQUITY

6 Months Ended

Dec. 31, 2020

Equity [Abstract]

STOCKHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Changes in the components of Stockholders’ equity were as follows for the periods indicated:


	Three Months Ended December 31
(Dollars in millions except per share data; shares in thousands)	Common Stock			Additional Paid-in Capital		Retained Earnings		Treasury Stock			Accumulated Other Comprehensive Net (Loss) Income		Non-controlling interests		Total Stockholders’ Equity
	Amount		Shares					Amount		Shares
Balance as of September 30, 2019	$	159	158,741	$	1,043	$	3,241	$	(3,278)	(33,246)	$	(615)	$	—	$	550
Net earnings						185									185
Other comprehensive (loss) income											14				14
Dividends to Clorox stockholders ($1.06 per share declared)						(133)									(133)
Stock-based compensation				13											13
Other employee stock plan activities				6		(1)		6		106					11
Treasury stock purchased								(85)		(577)					(85)
Balance as of December 31, 2019	$	159	158,741	$	1,062	$	3,292	$	(3,357)	(33,717)	$	(601)	$	—	$	555

Balance as of September 30, 2020	$	159	158,741	$	1,146	$	3,840	$	(3,407)	(32,704)	$	(623)	$	196	$	1,311
Net earnings						259							2		261
Other comprehensive (loss) income											48				48
Dividends to Clorox stockholders ($1.11 per share declared)						(141)									(141)
Dividends to non-controlling interests													(2)		(2)
Stock-based compensation				22											22
Other employee stock plan activities				8		(16)		89		667					81
Treasury stock purchased								(200)		(980)					(200)
Treasury stock retirement	(28)		(28,000)			(2,640)		2,668		28,000					—
Balance as of December 31, 2020	$	131	130,741	$	1,176	$	1,302	$	(850)	(5,017)	$	(575)	$	196	$	1,380


	Six Months Ended December 31
(Dollars in millions except per share data; shares in thousands)	Common Stock			Additional Paid-in Capital		Retained Earnings		Treasury Stock			Accumulated Other Comprehensive Net (Loss) Income		Non-controlling interests		Total Stockholders’ Equity
	Amount		Shares					Amount		Shares
Balance as of June 30, 2019	$	159	158,741	$	1,046	$	3,150	$	(3,194)	(33,055)	$	(602)	$	—	$	559
Cumulative effect of accounting changes, net of tax (1)						22									22
Net earnings						388									388
Other comprehensive (loss) income											1				1
Dividends to Clorox stockholders ($2.12 per share declared)						(267)									(267)
Stock-based compensation				19											19
Other employee stock plan activities				(3)		(1)		26		578					22
Treasury stock purchased								(189)		(1,240)					(189)
Balance as of December 31, 2019	$	159	158,741	$	1,062	$	3,292	$	(3,357)	(33,717)	$	(601)	$	—	$	555

Balance as of June 30, 2020	$	159	158,741	$	1,137	$	3,567	$	(3,315)	(32,543)	$	(640)	$	—	$	908
Net earnings						674							4		678
Other comprehensive (loss) income											65				65
Dividends to Clorox stockholders ($2.22 per share declared)						(282)									(282)
Dividends to noncontrolling interests													(6)		(6)
Business combinations including purchase accounting adjustments													198		198
Stock-based compensation				35											35
Other employee stock plan activities				4		(17)		97		950					84
Treasury stock purchased								(300)		(1,424)					(300)
Treasury stock retirement	(28)		(28,000)			(2,640)		2,668		28,000					—
Balance as of December 31, 2020	$	131	130,741	$	1,176	$	1,302	$	(850)	(5,017)	$	(575)	$	196	$	1,380

(1) As a result of adopting ASU No. 2016-02, “Leases (Topic 842),” on July 1, 2019, the Company recorded a cumulative effect of initially applying the new guidance as an adjustment to the fiscal year 2020 opening balance of Retained earnings.

On November 18, 2020 the Company retired 28 million shares of its treasury stock. These shares are now authorized but unissued. There was no effect on the Company’s overall equity position as a result of the retirement.

The Company has two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date.

Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:


	Three Months Ended						Six Months Ended
	12/31/2020			12/31/2019			12/31/2020			12/31/2019
	Amount		Shares (in thousands)	Amount		Shares (in thousands)	Amount		Shares (in thousands)	Amount		Shares (in thousands)
Open-market purchase program	$	—	—	$	85	577	$	—	—	$	85	577
Evergreen Program	200		980	—		—	300		1,424	104		663
Total stock repurchases	$	200	980	$	85	577	$	300	1,424	$	189	1,240

Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:


	Three Months Ended December 31
	Foreign currency translation adjustments		Net unrealized gains (losses) on derivatives		Pension and postretirement benefit adjustments		Accumulated other comprehensive net (loss) income
Balance as of September 30, 2019	$	(430)	$	(21)	$	(164)	$	(615)
Other comprehensive (loss) income before reclassifications	9		2		—		11
Amounts reclassified from Accumulated other comprehensive net (loss) income	—		2		1		3
Income tax benefit (expense)	—		—		—		—
Net current period other comprehensive (loss) income	9		4		1		14
Balance as of December 31, 2019	$	(421)	$	(17)	$	(163)	$	(601)

Balance as of September 30, 2020	$	(440)	$	(13)	$	(170)	$	(623)
Other comprehensive (loss) income before reclassifications	36		11		—		47
Amounts reclassified from Accumulated other comprehensive net (loss) income	—		2		2		4
Income tax benefit (expense), and other	1		(3)		(1)		(3)
Net current period other comprehensive (loss) income	37		10		1		48
Balance as of December 31, 2020	$	(403)	$	(3)	$	(169)	$	(575)

	Six Months Ended December 31
	Foreign currency translation adjustments		Net unrealized gains (losses) on derivatives		Pension and postretirement benefit adjustments		Accumulated other comprehensive net (loss) income
Balance as of June 30, 2019	$	(414)	$	(23)	$	(165)	$	(602)
Other comprehensive (loss) income before reclassifications	(6)		3		—		(3)
Amounts reclassified from Accumulated other comprehensive net (loss) income	—		4		3		7
Income tax benefit (expense)	(1)		(1)		(1)		(3)
Net current period other comprehensive (loss) income	(7)		6		2		1
Balance as of December 31, 2019	$	(421)	$	(17)	$	(163)	$	(601)

Balance as of June 30, 2020	$	(450)	$	(18)	$	(172)	$	(640)
Other comprehensive (loss) income before reclassifications	45		14		—		59
Amounts reclassified from Accumulated other comprehensive net (loss) income	—		5		4		9
Income tax benefit (expense), and other	2		(4)		(1)		(3)
Net current period other comprehensive (loss) income	47		15		3		65
Balance as of December 31, 2020	$	(403)	$	(3)	$	(169)	$	(575)

Included in foreign currency translation adjustments are re-measurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were no amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.

EMPLOYEE BENEFIT PLANS

6 Months Ended

Dec. 31, 2020

Retirement Benefits [Abstract]

EMPLOYEE BENEFIT PLANS

The following table summarizes the components of net periodic benefit cost for the Company’s retirement income plans:


	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Service cost	$	—	$	—	$	—	$	—
Interest cost	3		5		7		10
Expected return on plan assets (1)	(3)		(5)		(7)		(9)
Amortization of unrecognized items	2		2		5		4
Total	$	2	$	2	$	5	$	5

(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2021 net periodic benefit cost is 3.1%.

The net periodic benefit cost for the Company’s retirement health care plans was $(1) for both the three months and six months ended December 31, 2020 and 2019.

During the three months ended December 31, 2020 and 2019, the Company made $2 in contributions to its domestic retirement income plans. During the six months ended December 31, 2020 and 2019, the Company made $4 in contributions to its domestic retirement income plans.

Net periodic benefit costs are reflected in Other (income) expense, net.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

+ Details

OTHER CONTINGENCIES AND GUARANTEES	6 Months Ended
OTHER CONTINGENCIES AND GUARANTEES	Dec. 31, 2020
OTHER CONTINGENCIES AND GUARANTEES [Abstract]
OTHER CONTINGENCIES AND GUARANTEES	OTHER CONTINGENCIES AND GUARANTEES Contingencies The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $28 as of December 31, 2020 and June 30, 2020, for its share of aggregate future remediation costs related to these matters. One matter, which accounted for $14 of the recorded liability as of December 31, 2020 and June 30, 2020, relates to environmental costs associated with one of the Company’s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. As a result, the Company recorded in Other (income) expense, net an undiscounted liability for costs estimated to be incurred over a 30-year period, based on the option recommended in the Feasibility Study. However, as a result of ongoing discussions with regulators, in June 2017, the Company increased its recorded liability to $14, which reflects anticipated costs to implement additional remediation measures at this site. While the Company believes its latest estimate is reasonable, regulators could require the Company to implement one of the other options evaluated in the Feasibility Study, with estimated undiscounted costs of up to $28 over an estimated 30-year period, or require the Company to take other actions and incur costs not included in the study. Another matter in Dickinson County, Michigan, at the site of one of the Company’s former operations for which the Company is jointly and severally liable, accounted for $10 of the recorded liability, as of December 31, 2020 and June 30, 2020. This amount reflects the Company’s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing arrangement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company’s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. The Company’s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements, and the future availability of alternative clean-up technologies. The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements, product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company’s condensed consolidated financial statements taken as a whole. Guarantees In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company’s condensed consolidated financial statements taken as a whole. The Company had not recorded any material liabilities on the aforementioned guarantees as of December 31, 2020 and June 30, 2020. As of December 31, 2020, the Company was party to a letter of credit of $11, related to one of its insurance carriers, of which $0 had been drawn upon.

SEGMENT RESULTS

6 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

SEGMENT RESULTS

The Company operates through strategic business units (SBUs) that are aggregated into four reportable segments based on the economics and nature of the products sold: Health and Wellness, Household, Lifestyle and International. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2020.

Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.

The tables below present reportable segment information and a reconciliation of the segment information to the Company’s consolidated Net sales and Earnings before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate.


	Net sales
	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Health and Wellness	$	817	$	575	$	1,630	$	1,208
Household	411		342		911		703
Lifestyle	317		291		635		562
International	297		241		582		482
Corporate	—		—		—		—
Total	$	1,842	$	1,449	$	3,758	$	2,955

	Earnings (losses) before income taxes
	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Health and Wellness	$	247	$	134	$	498	$	304
Household	60		44		169		76
Lifestyle	89		91		191		162
International	30		31		154		70
Corporate	(94)		(65)		(154)		(119)
Total	$	332	$	235	$	858	$	493

All intersegment sales are eliminated and are not included in the Company’s reportable segments’ net sales.

Net sales to the Company’s largest customer, Wal-Mart Stores, Inc. and its affiliates, as a percentage of consolidated net sales, were 23% and 24% for the three and six months ended December 31, 2020, respectively, and 25% and 26% for the three and six months ended December 31, 2019, respectively.

The following table provides Net sales as a percentage of the Company’s consolidated net sales for the Company’s SBUs and for the periods indicated:


	Net sales
	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Cleaning	33	%	28	%	31	%	30	%
Professional Products	8	%	6	%	8	%	6	%
Vitamins, Minerals and Supplements	4	%	5	%	4	%	5	%
Health and Wellness	45	%	39	%	43	%	41	%
Bags and Wraps	11	%	13	%	11	%	12	%
Cat Litter	7	%	8	%	7	%	8	%
Grilling	4	%	3	%	7	%	4	%
Household	22	%	24	%	25	%	24	%
Food Products	9	%	10	%	9	%	9	%
Natural Personal Care	4	%	7	%	4	%	6	%
Water Filtration	4	%	3	%	4	%	4	%
Lifestyle	17	%	20	%	17	%	19	%
International	16	%	17	%	15	%	16	%
Total	100	%	100	%	100	%	100	%

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The unaudited interim condensed consolidated financial statements for the three and six months ended December 31, 2020 and 2019, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June 30, 2020, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.
Recently Issued Accounting Standards	Recently Issued Accounting Standards Recently Issued Accounting Standards Not Yet Adopted In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2019-12, “Income Taxes (ASC 740): Simplifying the Accounting for Income Taxes,” which improves consistency in the application of accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and by clarifying and amending existing guidance. The standard will be effective for the Company beginning in the first quarter of fiscal year 2022, with early adoption permitted. The amendments that are related to changes in ownership of foreign equity method investments or foreign subsidiaries are to be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments that are related to franchise taxes that are partially based on income are to be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU are to be applied on a prospective basis. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements. Recently Adopted Accounting Standards In January 2017, the FASB issued ASU No. 2017-04, “Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. The Company adopted this guidance as of July 1, 2020 on a prospective basis, and the adoption did not have a material impact on the Company’s consolidated financial statements, as the Company had no goodwill impairments to date during fiscal year 2021. The future impact of this new standard will depend on the specific facts and circumstances of future impairments that may occur, if any.
Fair Value Measurement	Fair Value Measurements Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions. As of December 31, 2020 and June 30, 2020, the Company’s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company’s nonqualified deferred compensation plans, which were classified as Level 1.
Segment Results	The Company operates through strategic business units (SBUs) that are aggregated into four reportable segments based on the economics and nature of the products sold: Health and Wellness, Household, Lifestyle and International. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2020. Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.

- Definition

Disclosure of accounting policy for segment reporting.

+ References + Details

BUSINESS ACQUIRED (Tables)

6 Months Ended

Dec. 31, 2020

Business Combinations [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the final purchase price allocation for the fair value of the joint venture’s assets acquired and liabilities assumed and the related deferred income taxes as of the acquisition date. The fair value of the assets acquired and liabilities assumed reflects the final insignificant measurement period adjustments related to goodwill, deferred income taxes and income taxes payable. The definite-lived intangibles acquired primarily represent the Company reacquiring previously licensed trademarks and customer relationships. The weighted-average estimated useful life of intangible assets subject to amortization is 9 years.


	Joint Venture
Goodwill	$	208
Reacquired rights (included in Other intangible assets, net)	138
Property, plant and equipment	46
Customer relationships (included in Other intangible assets, net)	10
Working capital, net (includes cash acquired of $26)	34
Noncurrent liabilities, net	(5)
Deferred income taxes	(19)
Total fair value of net assets	412
Less: Fair value of noncontrolling interests	(198)
Less: Fair value of previously held equity interest	(103)
Total purchase consideration	$	111

INVENTORIES, NET (Tables)

6 Months Ended

Dec. 31, 2020

Inventory Disclosure [Abstract]

Schedule of Inventories, Net

Inventories, net, consisted of the following as of:


	12/31/2020		6/30/2020
Finished goods	$	453	$	340
Raw materials and packaging	178		140
Work in process	10		7
LIFO allowances	(32)		(33)
Total	$	609	$	454

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Dec. 31, 2020

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]

Effects of Derivative Instruments Designated as Hedging Instruments on OCI

The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:


	Gains (losses) recognized in Other comprehensive (loss) income
	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Commodity purchase derivative contracts	$	6	$	3	$	7	$	3
Foreign exchange derivative contracts	(2)		(1)		(3)		—
Interest rate derivative contracts	7		—		10		—
Total	$	11	$	2	$	14	$	3

Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings


	Location of Gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings	Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings
		Three Months Ended				Six Months Ended
		12/31/2020		12/31/2019		12/31/2020		12/31/2019
Commodity purchase derivative contracts	Cost of products sold	$	(1)	$	(1)	$	(2)	$	(1)
Foreign exchange derivative contracts	Cost of products sold	—		—		—		—
Interest rate derivative contracts	Interest expense	(1)		(1)		(3)		(3)
Total		$	(2)	$	(2)	$	(5)	$	(4)

Schedule of Assets and Liabilities for Fair Value Disclosure

The following table provides information about the balance sheet classification and the fair values of the Company’s derivative instruments:


			12/31/2020				6/30/2020
	Balance Sheet Classification	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Commodity purchase futures contracts	Other current assets	1	$	2	$	2	$	—	$	—
Commodity purchase swaps contracts	Other current assets	2	1		1		—		—
Commodity purchase swaps contracts	Other assets	2	1		1		—		—
Interest rate forward contracts	Other assets	2	11		11		1		1
			$	15	$	15	$	1	$	1
Liabilities
Commodity purchase futures contracts	Accounts payable and accrued liabilities	1	$	—	$	—	$	1	$	1
Commodity purchase swaps contracts	Accounts payable and accrued liabilities	2	1		1		3		3
Foreign exchange forward contract	Accounts payable and accrued liabilities	2	3		3		1		1
			$	4	$	4	$	5	$	5

The following table provides information about the balance sheet classification and the fair values of the Company’s other assets and liabilities for which disclosure of fair value is required:


			12/31/2020				6/30/2020
	Balance Sheet Classification	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Investments, including money market funds	Cash and cash equivalents (a)	1	$	306	$	306	$	584	$	584
Time deposits	Cash and cash equivalents (a)	2	285		285		165		165


Trust assets for nonqualified deferred compensation plans	Other assets	1	128		128		100		100
			$	719	$	719	$	849	$	849
Liabilities


Current maturities of long-term debt and Long-term debt	Current maturities of long- term debt and Long-term debt (b)	2	2,783		3,050		2,780		3,051
			$	2,783	$	3,050	$	2,780	$	3,051

____________________

(a)Cash and cash equivalents are composed of time deposits and other interest bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.

(b)Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.

NET EARNINGS PER SHARE (EPS) (Tables)

6 Months Ended

Dec. 31, 2020

Earnings Per Share [Abstract]

Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares

The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:


	Three Months Ended		Six Months Ended
	12/31/2020	12/31/2019	12/31/2020	12/31/2019
Basic	126,216	125,440	126,281	125,632
Dilutive effect of stock options and other	1,919	1,439	2,176	1,566
Diluted	128,135	126,879	128,457	127,198

Antidilutive stock options and other	437	1,792	437	1,035

COMPREHENSIVE INCOME (Tables)

6 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Schedule of Comprehensive Income

The following table provides a summary of Comprehensive income for the periods indicated:


	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Net earnings	$	261	$	185	$	678	$	388
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments	37		9		47		(7)
Net unrealized gains (losses) on derivatives	10		4		15		6
Pension and postretirement benefit adjustments	1		1		3		2
Total other comprehensive (loss) income, net of tax	48		14		65		1
Comprehensive income	309		199		743		389
Less: Total comprehensive income attributable to noncontrolling interests	2		—		4		—
Total comprehensive income attributable to Clorox	$	307	$	199	$	739	$	389

STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Dec. 31, 2020

Equity [Abstract]

Schedule of Stockholders Equity

Changes in the components of Stockholders’ equity were as follows for the periods indicated:


	Three Months Ended December 31
(Dollars in millions except per share data; shares in thousands)	Common Stock			Additional Paid-in Capital		Retained Earnings		Treasury Stock			Accumulated Other Comprehensive Net (Loss) Income		Non-controlling interests		Total Stockholders’ Equity
	Amount		Shares					Amount		Shares
Balance as of September 30, 2019	$	159	158,741	$	1,043	$	3,241	$	(3,278)	(33,246)	$	(615)	$	—	$	550
Net earnings						185									185
Other comprehensive (loss) income											14				14
Dividends to Clorox stockholders ($1.06 per share declared)						(133)									(133)
Stock-based compensation				13											13
Other employee stock plan activities				6		(1)		6		106					11
Treasury stock purchased								(85)		(577)					(85)
Balance as of December 31, 2019	$	159	158,741	$	1,062	$	3,292	$	(3,357)	(33,717)	$	(601)	$	—	$	555

Balance as of September 30, 2020	$	159	158,741	$	1,146	$	3,840	$	(3,407)	(32,704)	$	(623)	$	196	$	1,311
Net earnings						259							2		261
Other comprehensive (loss) income											48				48
Dividends to Clorox stockholders ($1.11 per share declared)						(141)									(141)
Dividends to non-controlling interests													(2)		(2)
Stock-based compensation				22											22
Other employee stock plan activities				8		(16)		89		667					81
Treasury stock purchased								(200)		(980)					(200)
Treasury stock retirement	(28)		(28,000)			(2,640)		2,668		28,000					—
Balance as of December 31, 2020	$	131	130,741	$	1,176	$	1,302	$	(850)	(5,017)	$	(575)	$	196	$	1,380


	Six Months Ended December 31
(Dollars in millions except per share data; shares in thousands)	Common Stock			Additional Paid-in Capital		Retained Earnings		Treasury Stock			Accumulated Other Comprehensive Net (Loss) Income		Non-controlling interests		Total Stockholders’ Equity
	Amount		Shares					Amount		Shares
Balance as of June 30, 2019	$	159	158,741	$	1,046	$	3,150	$	(3,194)	(33,055)	$	(602)	$	—	$	559
Cumulative effect of accounting changes, net of tax (1)						22									22
Net earnings						388									388
Other comprehensive (loss) income											1				1
Dividends to Clorox stockholders ($2.12 per share declared)						(267)									(267)
Stock-based compensation				19											19
Other employee stock plan activities				(3)		(1)		26		578					22
Treasury stock purchased								(189)		(1,240)					(189)
Balance as of December 31, 2019	$	159	158,741	$	1,062	$	3,292	$	(3,357)	(33,717)	$	(601)	$	—	$	555

Balance as of June 30, 2020	$	159	158,741	$	1,137	$	3,567	$	(3,315)	(32,543)	$	(640)	$	—	$	908
Net earnings						674							4		678
Other comprehensive (loss) income											65				65
Dividends to Clorox stockholders ($2.22 per share declared)						(282)									(282)
Dividends to noncontrolling interests													(6)		(6)
Business combinations including purchase accounting adjustments													198		198
Stock-based compensation				35											35
Other employee stock plan activities				4		(17)		97		950					84
Treasury stock purchased								(300)		(1,424)					(300)
Treasury stock retirement	(28)		(28,000)			(2,640)		2,668		28,000					—
Balance as of December 31, 2020	$	131	130,741	$	1,176	$	1,302	$	(850)	(5,017)	$	(575)	$	196	$	1,380

(1) As a result of adopting ASU No. 2016-02, “Leases (Topic 842),” on July 1, 2019, the Company recorded a cumulative effect of initially applying the new guidance as an adjustment to the fiscal year 2020 opening balance of Retained earnings.

Schedule of Share Repurchases Under Authorized Programs

Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:


	Three Months Ended						Six Months Ended
	12/31/2020			12/31/2019			12/31/2020			12/31/2019
	Amount		Shares (in thousands)	Amount		Shares (in thousands)	Amount		Shares (in thousands)	Amount		Shares (in thousands)
Open-market purchase program	$	—	—	$	85	577	$	—	—	$	85	577
Evergreen Program	200		980	—		—	300		1,424	104		663
Total stock repurchases	$	200	980	$	85	577	$	300	1,424	$	189	1,240

Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income

Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:


	Three Months Ended December 31
	Foreign currency translation adjustments		Net unrealized gains (losses) on derivatives		Pension and postretirement benefit adjustments		Accumulated other comprehensive net (loss) income
Balance as of September 30, 2019	$	(430)	$	(21)	$	(164)	$	(615)
Other comprehensive (loss) income before reclassifications	9		2		—		11
Amounts reclassified from Accumulated other comprehensive net (loss) income	—		2		1		3
Income tax benefit (expense)	—		—		—		—
Net current period other comprehensive (loss) income	9		4		1		14
Balance as of December 31, 2019	$	(421)	$	(17)	$	(163)	$	(601)

Balance as of September 30, 2020	$	(440)	$	(13)	$	(170)	$	(623)
Other comprehensive (loss) income before reclassifications	36		11		—		47
Amounts reclassified from Accumulated other comprehensive net (loss) income	—		2		2		4
Income tax benefit (expense), and other	1		(3)		(1)		(3)
Net current period other comprehensive (loss) income	37		10		1		48
Balance as of December 31, 2020	$	(403)	$	(3)	$	(169)	$	(575)

	Six Months Ended December 31
	Foreign currency translation adjustments		Net unrealized gains (losses) on derivatives		Pension and postretirement benefit adjustments		Accumulated other comprehensive net (loss) income
Balance as of June 30, 2019	$	(414)	$	(23)	$	(165)	$	(602)
Other comprehensive (loss) income before reclassifications	(6)		3		—		(3)
Amounts reclassified from Accumulated other comprehensive net (loss) income	—		4		3		7
Income tax benefit (expense)	(1)		(1)		(1)		(3)
Net current period other comprehensive (loss) income	(7)		6		2		1
Balance as of December 31, 2019	$	(421)	$	(17)	$	(163)	$	(601)

Balance as of June 30, 2020	$	(450)	$	(18)	$	(172)	$	(640)
Other comprehensive (loss) income before reclassifications	45		14		—		59
Amounts reclassified from Accumulated other comprehensive net (loss) income	—		5		4		9
Income tax benefit (expense), and other	2		(4)		(1)		(3)
Net current period other comprehensive (loss) income	47		15		3		65
Balance as of December 31, 2020	$	(403)	$	(3)	$	(169)	$	(575)

EMPLOYEE BENEFIT PLANS (Tables)

6 Months Ended

Dec. 31, 2020

Retirement Benefits [Abstract]

Schedule of Components of Net Periodic Benefit Cost

The following table summarizes the components of net periodic benefit cost for the Company’s retirement income plans:


	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Service cost	$	—	$	—	$	—	$	—
Interest cost	3		5		7		10
Expected return on plan assets (1)	(3)		(5)		(7)		(9)
Amortization of unrecognized items	2		2		5		4
Total	$	2	$	2	$	5	$	5

(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2021 net periodic benefit cost is 3.1%.

SEGMENT RESULTS (Tables)

6 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Selected Financial Information Relating to the Company's Segments

The tables below present reportable segment information and a reconciliation of the segment information to the Company’s consolidated Net sales and Earnings before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate.


	Net sales
	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Health and Wellness	$	817	$	575	$	1,630	$	1,208
Household	411		342		911		703
Lifestyle	317		291		635		562
International	297		241		582		482
Corporate	—		—		—		—
Total	$	1,842	$	1,449	$	3,758	$	2,955

	Earnings (losses) before income taxes
	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Health and Wellness	$	247	$	134	$	498	$	304
Household	60		44		169		76
Lifestyle	89		91		191		162
International	30		31		154		70
Corporate	(94)		(65)		(154)		(119)
Total	$	332	$	235	$	858	$	493

The following table provides Net sales as a percentage of the Company’s consolidated net sales for the Company’s SBUs and for the periods indicated:


	Net sales
	Three Months Ended				Six Months Ended
	12/31/2020		12/31/2019		12/31/2020		12/31/2019
Cleaning	33	%	28	%	31	%	30	%
Professional Products	8	%	6	%	8	%	6	%
Vitamins, Minerals and Supplements	4	%	5	%	4	%	5	%
Health and Wellness	45	%	39	%	43	%	41	%
Bags and Wraps	11	%	13	%	11	%	12	%
Cat Litter	7	%	8	%	7	%	8	%
Grilling	4	%	3	%	7	%	4	%
Household	22	%	24	%	25	%	24	%
Food Products	9	%	10	%	9	%	9	%
Natural Personal Care	4	%	7	%	4	%	6	%
Water Filtration	4	%	3	%	4	%	4	%
Lifestyle	17	%	20	%	17	%	19	%
International	16	%	17	%	15	%	16	%
Total	100	%	100	%	100	%	100	%

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)	6 Months Ended
	Dec. 31, 2020 USD ($)
Accounting Policies [Abstract]
Goodwill impairment	$ 0

BUSINESS ACQUIRED (Narrative) (Details) - USD ($)		3 Months Ended		6 Months Ended
BUSINESS ACQUIRED (Narrative) (Details) - USD ($)	Jul. 09, 2020	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2020	Jun. 30, 2020
Business Combination, Separately Recognized Transactions [Line Items]
Total purchase consideration	$ 111,000,000
Cash paid	100,000,000
Loss on settlement	11,000,000
Goodwill		$ 1,803,000,000		$ 1,803,000,000	$ 1,577,000,000
Non-recurring, non-cash gain			$ 85,000,000
Joint venture net sales		$ 23,000,000		$ 46,000,000
Joint Venture In Kingdom Of Saudi Arabia [Member]
Business Combination, Separately Recognized Transactions [Line Items]
Total purchase consideration	111,000,000
Goodwill	208,000,000
Goodwill deductible for tax purposes	$ 0
The weighted-average estimated useful life of intangible assets subject to amortization	9 years
Joint Venture In Kingdom Of Saudi Arabia [Member]
Business Combination, Separately Recognized Transactions [Line Items]
Noncontrolling interest, ownership percentage by parent	51.00%
Joint Venture In Kingdom Of Saudi Arabia [Member]
Business Combination, Separately Recognized Transactions [Line Items]
Equity method investment, ownership percentage	30.00%
Equity method investments	$ 27,000,000

BUSINESS ACQUIRED (Fair Value Of Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Millions	Jul. 09, 2020	Dec. 31, 2020	Jun. 30, 2020
Business Combination, Separately Recognized Transactions [Line Items]
Goodwill		$ 1,803	$ 1,577
Total purchase consideration	$ 111
Joint Venture In Kingdom Of Saudi Arabia [Member]
Business Combination, Separately Recognized Transactions [Line Items]
Goodwill	208
Property, plant and equipment	46
Working capital, net (includes cash acquired of $26)	34
Noncurrent liabilities, net	(5)
Deferred income taxes	(19)
Total fair value of net assets	412
Less: Fair value of noncontrolling interests	(198)
Less: Fair value of previously held equity interest	(103)
Total purchase consideration	111
Cash acquired	26
Contractual Rights [Member] \| Joint Venture In Kingdom Of Saudi Arabia [Member]
Business Combination, Separately Recognized Transactions [Line Items]
Reacquired rights (included in Other intangible assets, net)	138
Customer relationships (included in Other intangible assets, net)	138
Customer Relationships [Member] \| Joint Venture In Kingdom Of Saudi Arabia [Member]
Business Combination, Separately Recognized Transactions [Line Items]
Reacquired rights (included in Other intangible assets, net)	10
Customer relationships (included in Other intangible assets, net)	$ 10

INVENTORIES, NET (Details) - USD ($) $ in Millions	Dec. 31, 2020	Jun. 30, 2020
Inventory Disclosure [Abstract]
Finished goods	$ 453	$ 340
Raw materials and packaging	178	140
Work in process	10	7
LIFO allowances	(32)	(33)
Total	$ 609	$ 454

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2020
Derivative [Line Items]
Maximum duration, foreign exchange contracts	2 years
Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months	$ (6,000,000)
Derivative instruments subject to contractually defined counterparty liability position limits	2,000,000	$ 3,000,000
Interest Rate Contract [Member]
Derivative [Line Items]
Notional amount	$ 300,000,000	225,000,000
Maximum duration, interest rate contracts	3 years
Purchases of Inventory [Member] \| Foreign Exchange Contract [Member]
Derivative [Line Items]
Notional amount	$ 57,000,000	70,000,000
Total Commodity Purchase Derivative Contracts [Member]
Derivative [Line Items]
Maximum duration, commodity contracts	2 years
Notional amount	$ 21,000,000	27,000,000
Jet Fuel Swaps [Member]
Derivative [Line Items]
Notional amount	10,000,000	13,000,000
Soybean Oil Futures [Member]
Derivative [Line Items]
Notional amount	11,000,000	14,000,000
Soybean Oil Futures [Member] \| Commodity Contract [Member]
Derivative [Line Items]
Cash margin balances amount	$ 3,000,000	$ 2,000,000

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) recognized in Other comprehensive (loss) income	$ 11	$ 2	$ 14	$ 3
Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings	(2)	(2)	(5)	(4)
Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) recognized in Other comprehensive (loss) income	6	3	7	3
Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings	(1)	(1)	(2)	(1)
Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) recognized in Other comprehensive (loss) income	(2)	(1)	(3)	0
Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings	0	0	0	0
Interest Rate Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) recognized in Other comprehensive (loss) income	7	0	10	0
Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings	$ (1)	$ (1)	$ (3)	$ (3)

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Jun. 30, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 732	$ 871
Total assets	6,855	6,213
Total liabilities	5,475	5,305
Reported Value Measurement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	15	1
Derivative liabilities	4	5
Total assets	719	849
Total liabilities	2,783	2,780
Estimate of Fair Value Measurement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	15	1
Derivative liabilities	4	5
Total other assets in the fair value hierarchy	719	849
Total other liabilities in the fair value hierarchy	3,050	3,051
Other Current Assets [Member] \| Fair Value, Inputs, Level 1 [Member] \| Reported Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	2	0
Other Current Assets [Member] \| Fair Value, Inputs, Level 1 [Member] \| Estimate of Fair Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	2	0
Other Current Assets [Member] \| Fair Value, Inputs, Level 2 [Member] \| Reported Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	1	0
Other Current Assets [Member] \| Fair Value, Inputs, Level 2 [Member] \| Estimate of Fair Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	1	0
Other Assets [Member] \| Fair Value, Inputs, Level 2 [Member] \| Reported Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	1	0
Other Assets [Member] \| Fair Value, Inputs, Level 2 [Member] \| Reported Value Measurement [Member] \| Interest Rate Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	11	1
Other Assets [Member] \| Fair Value, Inputs, Level 2 [Member] \| Estimate of Fair Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	1	0
Other Assets [Member] \| Fair Value, Inputs, Level 2 [Member] \| Estimate of Fair Value Measurement [Member] \| Interest Rate Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	11	1
Other Assets [Member] \| Trust Assets for nonqualified deferred compensation plans [Member] \| Fair Value, Inputs, Level 1 [Member] \| Reported Value Measurement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trust assets for nonqualified deferred compensation plans	128	100
Other Assets [Member] \| Trust Assets for nonqualified deferred compensation plans [Member] \| Fair Value, Inputs, Level 1 [Member] \| Estimate of Fair Value Measurement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trust assets for nonqualified deferred compensation plans	128	100
Accounts Payable and Accrued Liabilities [Member] \| Fair Value, Inputs, Level 1 [Member] \| Reported Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	0	1
Accounts Payable and Accrued Liabilities [Member] \| Fair Value, Inputs, Level 1 [Member] \| Estimate of Fair Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	0	1
Accounts Payable and Accrued Liabilities [Member] \| Fair Value, Inputs, Level 2 [Member] \| Reported Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	1	3
Accounts Payable and Accrued Liabilities [Member] \| Fair Value, Inputs, Level 2 [Member] \| Reported Value Measurement [Member] \| Foreign Exchange Forward Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	3	1
Accounts Payable and Accrued Liabilities [Member] \| Fair Value, Inputs, Level 2 [Member] \| Estimate of Fair Value Measurement [Member] \| Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	1	3
Accounts Payable and Accrued Liabilities [Member] \| Fair Value, Inputs, Level 2 [Member] \| Estimate of Fair Value Measurement [Member] \| Foreign Exchange Forward Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	3	1
Cash and Cash Equivalents [Member] \| Fair Value, Inputs, Level 1 [Member] \| Reported Value Measurement [Member] \| Investments, including money market funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	306	584
Cash and Cash Equivalents [Member] \| Fair Value, Inputs, Level 1 [Member] \| Estimate of Fair Value Measurement [Member] \| Investments, including money market funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	306	584
Cash and Cash Equivalents [Member] \| Fair Value, Inputs, Level 2 [Member] \| Reported Value Measurement [Member] \| Time deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	285	165
Cash and Cash Equivalents [Member] \| Fair Value, Inputs, Level 2 [Member] \| Estimate of Fair Value Measurement [Member] \| Time deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	285	165
Current maturities of long-term debt and Long-term debt [Member] \| Fair Value, Inputs, Level 2 [Member] \| Reported Value Measurement [Member] \| Long-term Debt [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Current maturities of long-term debt and Long-term debt	2,783	2,780
Current maturities of long-term debt and Long-term debt [Member] \| Fair Value, Inputs, Level 2 [Member] \| Estimate of Fair Value Measurement [Member] \| Long-term Debt [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Current maturities of long-term debt and Long-term debt	$ 3,050	$ 3,051

INCOME TAXES (Narrative) (Details)	3 Months Ended		6 Months Ended
INCOME TAXES (Narrative) (Details)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Effective tax rate on earnings from continuing operations	21.20%	21.00%	20.90%	21.30%

NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share [Abstract]
Basic (in shares)	126,216	125,440	126,281	125,632
Dilutive effect of stock options and other (in shares)	1,919	1,439	2,176	1,566
Diluted (in shares)	128,135	126,879	128,457	127,198
Antidilutive stock options and other (in shares)	437	1,792	437	1,035

COMPREHENSIVE INCOME (Schedule of Comprehensive Income) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Stockholders' Equity Note [Abstract]
Net earnings	$ 261	$ 185	$ 678	$ 388
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments	37	9	47	(7)
Net unrealized gains (losses) on derivatives	10	4	15	6
Pension and postretirement benefit adjustments	1	1	3	2
Total other comprehensive (loss) income, net of tax	48	14	65	1
Comprehensive income	309	199	743	389
Less: Total comprehensive income attributable to noncontrolling interests	2	0	4	0
Total comprehensive income attributable to Clorox	$ 307	$ 199	$ 739	$ 389

STOCKHOLDERS' EQUITY (Schedule of Equity) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions		3 Months Ended		6 Months Ended
	Nov. 18, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Class of Stock [Line Items]
Dividends declared per share (in dollars per share)		$ 1.11	$ 1.06	$ 2.22	$ 2.12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning		$ 1,311	$ 550	$ 908	$ 559
Net earnings		261	185	678	388
Other comprehensive (loss) income		48	14	65	1
Dividends		(141)	(133)	(282)	(267)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders		(2)		(6)
Business combinations including purchase accounting adjustments				198
Stock-based compensation		22	13	35	19
Other employee stock plan activities		81	11	84	22
Treasury stock purchased		$ (200)	$ (85)	$ (300)	$ (189)
Treasury stock purchased (in shares)		(980)	(577)	(1,424)	(1,240)
Treasury stock retirement		$ 0		$ 0
Balance, ending		1,380	$ 555	1,380	$ 555
Cumulative Effect of Accounting Changes, Net of Tax [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning					22
Common Stock [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning		$ 159	$ 159	$ 159	$ 159
Balance, beginning (in shares)		158,741	158,741	158,741	158,741
Treasury stock retirement		$ (28)		$ (28)
Treasury stock retirement (in shares)		28,000		28,000
Balance, ending		$ 131	$ 159	$ 131	$ 159
Balance, ending (in shares)		130,741	158,741	130,741	158,741
Additional Paid-in Capital [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning		$ 1,146	$ 1,043	$ 1,137	$ 1,046
Stock-based compensation		22	13	35	19
Other employee stock plan activities		8	6	4	(3)
Balance, ending		1,176	1,062	1,176	1,062
Retained Earnings [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning		3,840	3,241	3,567	3,150
Net earnings		259	185	674	388
Dividends		(141)	(133)	(282)	(267)
Other employee stock plan activities		(16)	(1)	(17)	(1)
Treasury stock retirement		(2,640)		(2,640)
Balance, ending		1,302	3,292	1,302	3,292
Retained Earnings [Member] \| Cumulative Effect of Accounting Changes, Net of Tax [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning					22
Treasury Stock [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning		$ (3,407)	$ (3,278)	$ (3,315)	$ (3,194)
Balance, beginning (in shares)		32,704	33,246	32,543	33,055
Other employee stock plan activities		$ 89	$ 6	$ 97	$ 26
Other employee stock plan activities (in shares)		667	106	950	578
Treasury stock purchased		$ (200)	$ (85)	$ (300)	$ (189)
Treasury stock purchased (in shares)		(980)	(577)	(1,424)	(1,240)
Treasury stock retirement		$ 2,668		$ 2,668
Treasury stock retirement (in shares)	28,000	28,000		28,000
Balance, ending		$ (850)	$ (3,357)	$ (850)	$ (3,357)
Balance, ending (in shares)		5,017	33,717	5,017	33,717
Accumulated other comprehensive net (loss) income [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning		$ (623)	$ (615)	$ (640)	$ (602)
Other comprehensive (loss) income		48	14	65	1
Balance, ending		(575)	(601)	(575)	(601)
Noncontrolling Interest [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning		196	0	0	0
Net earnings		2		4
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders		(2)		(6)
Business combinations including purchase accounting adjustments				198
Treasury stock retirement
Balance, ending		$ 196	$ 0	$ 196	$ 0

STOCKHOLDERS' EQUITY (Narrative) (Details) shares in Thousands		3 Months Ended		6 Months Ended
	Nov. 18, 2020 shares	Dec. 31, 2020 USD ($) repurchase_program shares	Dec. 31, 2019 USD ($) repurchase_program	Dec. 31, 2020 USD ($) repurchase_program shares	Dec. 31, 2019 USD ($) repurchase_program
Accumulated Other Comprehensive Income (Loss) [Line Items]
Treasury stock retirement		$ 0		$ 0
Number of repurchase programs \| repurchase_program		2	2	2	2
Amounts reclassified from accumulated other comprehensive net (loss) income		$ (4,000,000)	$ (3,000,000)	$ (9,000,000)	$ (7,000,000)
Long-Term Inter-Company Loans [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amounts reclassified from accumulated other comprehensive net (loss) income		$ 0	$ 0	$ 0	$ 0
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Treasury stock retired \| shares	28,000	28,000		28,000
Treasury stock retirement		$ 2,668,000,000		$ 2,668,000,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Treasury stock retired \| shares		28,000		28,000
Treasury stock retirement		$ (28,000,000)		$ (28,000,000)
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Treasury stock retirement		(2,640,000,000)		(2,640,000,000)
$2 Billion Open-Market Purchase Program [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock repurchase program, authorized amount		2,000,000,000		2,000,000,000
Evergreen Program [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Authorization limit		$ 0		$ 0

STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Share Repurchase Programs [Line Items]
Value of shares repurchased	$ 200	$ 85	$ 300	$ 189
Shares repurchased (in shares)	980	577	1,424	1,240
$2 Billion Open-Market Purchase Program [Member]
Share Repurchase Programs [Line Items]
Value of shares repurchased	$ 0	$ 85	$ 0	$ 85
Shares repurchased (in shares)	0	577	0	577
Evergreen Program [Member]
Share Repurchase Programs [Line Items]
Value of shares repurchased	$ 200	$ 0	$ 300	$ 104
Shares repurchased (in shares)	980	0	1,424	663

STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance, beginning			$ 908
Other comprehensive (loss) income before reclassifications	$ 47	$ 11	59	$ (3)
Amounts reclassified from Accumulated other comprehensive net (loss) income	4	3	9	7
Income tax benefit (expense)	(3)	0	(3)	(3)
Net current period other comprehensive (loss) income	48	14	65	1
Balance, ending	1,184		1,184
Foreign currency translation adjustments [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance, beginning	(440)	(430)	(450)	(414)
Other comprehensive (loss) income before reclassifications	36	9	45	(6)
Amounts reclassified from Accumulated other comprehensive net (loss) income	0	0	0	0
Income tax benefit (expense)	1	0	2	(1)
Net current period other comprehensive (loss) income	37	9	47	(7)
Balance, ending	(403)	(421)	(403)	(421)
Net unrealized gains (losses) on derivatives [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance, beginning	(13)	(21)	(18)	(23)
Other comprehensive (loss) income before reclassifications	11	2	14	3
Amounts reclassified from Accumulated other comprehensive net (loss) income	2	2	5	4
Income tax benefit (expense)	(3)	0	(4)	(1)
Net current period other comprehensive (loss) income	10	4	15	6
Balance, ending	(3)	(17)	(3)	(17)
Pension and postretirement benefit adjustments [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance, beginning	(170)	(164)	(172)	(165)
Other comprehensive (loss) income before reclassifications	0	0	0	0
Amounts reclassified from Accumulated other comprehensive net (loss) income	2	1	4	3
Income tax benefit (expense)	(1)	0	(1)	(1)
Net current period other comprehensive (loss) income	1	1	3	2
Balance, ending	(169)	(163)	(169)	(163)
Accumulated other comprehensive net (loss) income [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance, beginning	(623)	(615)	(640)	(602)
Balance, ending	$ (575)	$ (601)	$ (575)	$ (601)

EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Total	$ 1	$ 1	$ 1	$ 1
Weighted average long-term expected rate or return on plan assets			3.10%
Other Postretirement Benefits Plan [Member] \| Retirement Income Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	0	0	$ 0	0
Interest cost	3	5	7	10
Expected return on plan assets	(3)	(5)	(7)	(9)
Amortization of unrecognized items	2	2	5	4
Total	$ 2	$ 2	$ 5	$ 5

EMPLOYEE BENEFIT PLANS (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit	$ (1)	$ (1)	$ (1)	$ (1)
Retirement Income Plans [Member] \| UNITED STATES
Defined Benefit Plan Disclosure [Line Items]
Discretionary contributions	$ 2	$ 2	$ 4	$ 4

- Definition

Amount of contribution received by defined benefit plan from employer which increases plan assets.

+ References + Details

OTHER CONTINGENCIES AND GUARANTEES (Details) - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2020	Jun. 30, 2017
Loss Contingencies [Line Items]
Liability for aggregate future remediation costs	$ 28	$ 28
Letter of credit	11
Letter of credit, amount outstanding	0
Alameda County, California Matter [Member]
Loss Contingencies [Line Items]
Liability for aggregate future remediation costs	$ 14	14	$ 14
Remediation period	30 years
Maximum undiscounted costs	$ 28
Dickinson County, Michigan Matter [Member]
Loss Contingencies [Line Items]
Liability for aggregate future remediation costs	$ 10	$ 10
Remediation period	30 years
Percentage of liability for aggregate remediation and associated costs, other than legal fees	24.30%

SEGMENT RESULTS (Narrative) (Details) - reportable_segment	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Concentration Risk [Line Items]
Number of reportable segments			4
Revenue from Contract with Customer [Member] \| Customer Concentration Risk [Member] \| Walmart Stores, Inc. [Member]
Concentration Risk [Line Items]
Concentration percentage	23.00%	25.00%	24.00%	26.00%

SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net sales	$ 1,842	$ 1,449	$ 3,758	$ 2,955
Earnings (losses) before income taxes	$ 332	$ 235	$ 858	$ 493
Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	100.00%	100.00%	100.00%	100.00%
Health and Wellness [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	45.00%	39.00%	43.00%	41.00%
Health and Wellness [Member] \| Cleaning [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	33.00%	28.00%	31.00%	30.00%
Health and Wellness [Member] \| Professional Products [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	8.00%	6.00%	8.00%	6.00%
Health and Wellness [Member] \| Vitamins, Minerals and Supplements [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	4.00%	5.00%	4.00%	5.00%
Household [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	22.00%	24.00%	25.00%	24.00%
Household [Member] \| Bags and Wraps [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	11.00%	13.00%	11.00%	12.00%
Household [Member] \| Cat Litter [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	7.00%	8.00%	7.00%	8.00%
Household [Member] \| Grilling [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	4.00%	3.00%	7.00%	4.00%
Lifestyle [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	17.00%	20.00%	17.00%	19.00%
Lifestyle [Member] \| Food Products [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	9.00%	10.00%	9.00%	9.00%
Lifestyle [Member] \| Natural Personal Care [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	4.00%	7.00%	4.00%	6.00%
Lifestyle [Member] \| Water Filtration [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	4.00%	3.00%	4.00%	4.00%
International [Member] \| Product Concentration Risk [Member] \| Revenue from Contract with Customer [Member]
Segment Reporting Information [Line Items]
Concentration percentage	16.00%	17.00%	15.00%	16.00%
Operating Segments [Member] \| Health and Wellness [Member]
Segment Reporting Information [Line Items]
Net sales	$ 817	$ 575	$ 1,630	$ 1,208
Earnings (losses) before income taxes	247	134	498	304
Operating Segments [Member] \| Household [Member]
Segment Reporting Information [Line Items]
Net sales	411	342	911	703
Earnings (losses) before income taxes	60	44	169	76
Operating Segments [Member] \| Lifestyle [Member]
Segment Reporting Information [Line Items]
Net sales	317	291	635	562
Earnings (losses) before income taxes	89	91	191	162
Operating Segments [Member] \| International [Member]
Segment Reporting Information [Line Items]
Net sales	297	241	582	482
Earnings (losses) before income taxes	30	31	154	70
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Net sales	0	0	0	0
Earnings (losses) before income taxes	$ (94)	$ (65)	$ (154)	$ (119)